Lieff Cabraser Civil Justice Blog
Brendan Glackin Speaks at PLI California Trial Advocacy Program 2016 Seminar

Brendan Glackin Speaks at PLI California Trial Advocacy Program 2016 Seminar

Lieff Cabraser partner Brendan P. Glackin will be participating in the Practising Law Institute’s (PLI) California Trial Advocacy 2016 Seminar on August 3 in San Francisco, California. Mr. Glackin will be featured on a distinguished panel of guests, presenting as part of a panel and live webcast titled “Direct Examination; Trial Objections,” which will cover witness preparation, organizing direct examinations, the utilization of documents as evidence, and how to make key trial objections.

Other panel topics include motions in limine and deposition testimony, jury selection, opening statements and closing arguments, expert witnesses at trial, evidence, and cross-examinations.

Founded in 1933, the Practising Law Institute (PLI) is a nonprofit organization that furthers legal education and professional business training for attorneys and professionals in the legal realm. It is dedicated to providing the legal community with advanced education through seminars, workshops, live webcasts, and on-demand learning. You can sign up for the August 3 seminar here.

About Brendan Glackin

A partner in Lieff Cabraser’s San Francisco office, Mr. Glackin represented direct purchasers of titanium dioxide in a nationwide antitrust class action lawsuit; direct purchasers of flat-panel TV screens in litigation against the world’s leading LCDs manufacturers for conspiring to fix prices; retailers in a monopolization pricing lawsuit against Abbott Laboratories charging that the company exploited the market for AIDS medicines used in conjunction with Abbott’s prescription drug Norvir, and represented employees in the high-tech workers class action alleging that major Silicon Valley firms colluded to reduce competition for workers. He presently serves on the Lieff Cabraser team representing The Charles Schwab Corporation in the LIBOR manipulation suit.